{"id":2401,"date":"2026-03-26T14:01:31","date_gmt":"2026-03-26T14:01:31","guid":{"rendered":"https:\/\/stock999.top\/?p=2401"},"modified":"2026-03-26T14:01:31","modified_gmt":"2026-03-26T14:01:31","slug":"tom-brady-says-glp-1-drugs-are-a-kick-start-not-a-shortcut","status":"publish","type":"post","link":"https:\/\/stock999.top\/?p=2401","title":{"rendered":"Tom Brady says GLP-1 drugs are a &#8216;kick start,&#8217; not a shortcut"},"content":{"rendered":"<p><img src=\"https:\/\/static.foxbusiness.com\/foxbusiness.com\/content\/uploads\/2026\/03\/tom-brady-3-20-2026.jpg\" \/>     <\/p>\n<p>eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss GLP-1 market growth and the company\u2019s latest funding round on &#8216;Mornings with Maria.&#8217;<\/p>\n<p>As the market for GLP-1 weight-loss drugs explodes toward a projected $150 billion, NFL legend Tom Brady is stepping into the arena \u2014 not to promote a magic pill, but to infuse the clinical surge with his trademark &#8220;TB12&#8221; discipline.<\/p>\n<p>&#8220;Making a difference in other people&#8217;s lives, trying to share some of the things that have been in my mind that I&#8217;ve learned from incredible mentors, understanding and trying to inspire through the different people that have come into my life to communicate the messages that I&#8217;ve been able to get, that have helped me kind of live my dream, and I want to do that for others,&#8221; Brady said in an exclusive &#8220;Mornings with Maria&#8221; interview that aired Thursday.<\/p>\n<p>The seven-time Super Bowl champion and eMed CEO Linda Yaccarino joined forces to announce a massive $200 million funding round, valuing the digital health company at more than $2 billion. The duo is aiming to revolutionize &#8220;population health&#8221; by using AI and clinical oversight to provide employers with a sustainable way to offer GLP-1 weight-loss medications like Ozempic and Mounjaro, while slashing corporate insurance claims.<\/p>\n<p>&#8220;The raise confirms immense momentum and establishes us as the definitive company for population health and helping employers break the runaway health care costs and break their cost curve,&#8221; Yaccarino told Bartiromo.<\/p>\n<p>TOM BRADY SAYS POST-N.F.L. LIFE IS ABOUT \u2018BUILDING TRUST\u2019 AS HE MAKES BUSINESS PLAY WITH HERTZ<\/p>\n<p>&#8220;When you have overweight or obese people, their health care costs are two times the average employee who&#8217;s not obese,&#8221; she continued. &#8220;So that is the question that hasn&#8217;t been answered yet, that finally, eMed steps in, is able to deliver those solutions to employers all over the country.&#8221;<\/p>\n<p>Tom Brady at the Fanatics Flag Football Classic Press Conference &amp; Practice held at BMO Stadium on March 20, 2026, in Los Angeles, California. (Getty Images)<\/p>\n<p>While many Americans use GLP-1s as an easy weight-loss solution, Brady views the eMed platform as a kickstart for those who lack the biological advantage of natural high-willpower. He insists that medication must be based on a foundation of clinical support and personal accountability.<\/p>\n<p>&#8220;This isn&#8217;t about shortcuts for anybody. This is about a well-delivered program for people to kick-start their health journey in certain ways,&#8221; Brady clarified. &#8220;I\u2019ve been so fortunate to be around the best professionals, the best doctors, the best trainers, the best nutritionists. And I realized how fortunate I was at having that guidance.&#8221;<\/p>\n<p>&#8220;I really want to kind of break the stigma around the fact that, you know, discipline and hard work and willpower are something that\u2026 we&#8217;re born with. I was born with that, and I have the ability to do that. I think there&#8217;s a lot of other people that that is something that is more of a struggle,&#8221; he added. &#8220;But we need to be able to provide support for those people as well.&#8221;<\/p>\n<p>Seven-time Super Bowl champion Tom Brady and Aescape CEO Eric Litman discuss the NFL star\u2019s partnership with next-generation AI massage technology on \u2018The Claman Countdown.\u2019<\/p>\n<p>Brady further detailed how his most valuable asset required a level of maintenance that is only now becoming mainstream.<\/p>\n<p>&#8220;I realized because I was an athlete, my body was my asset,&#8221; the former quarterback said. &#8220;If I loved playing football and I love being on the field, then I love performing my very best. I had to treat my body, you know, a very certain way. I tried to get a lot of muscle work to repair injured tissue. I hydrated all the time. I tried to eat a low inflammatory diet. I tried to get the proper rest.&#8221;<\/p>\n<p>&#8220;How can I ever stop? This is my life, I tell you, I&#8217;ve been so obsessed with training. I would feel horrible and worse if I didn&#8217;t move all the time. I feel like I have a lot of energy&#8230; I want to stay active. I have three children. I want to go out there and play basketball and swim and hit the golf ball, and play volleyball with my daughter in the backyard,&#8221; Brady said.<\/p>\n<p>GET FOX BUSINESS ON THE GO BY CLICKING HERE<\/p>\n<p>Novo Nordisk President and CEO Mike Doustdar joins \u2018Mornings with Maria\u2019 to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims &amp; Hers and talks with the Trump administration on drug pricing.<\/p>\n<p>Yaccarino \u2014 the former CEO of X Corp who declined to comment on Wednesday&#8217;s social media verdict \u2014 explained that the goal of eMed is to take Brady\u2019s &#8220;rigor&#8221; and apply it to the American workforce and minimize chronic diseases.<\/p>\n<p>&#8220;Ninety-percent of people stay on our program. They do two things: First, and most important, what Tom was referencing, they get healthier,&#8221; she said. &#8220;And when you get people on the program, when you deliver those health outcomes, that&#8217;s the secret sauce for employers, for CEOs, CFOs \u2014 who you have on your show all the time \u2014 because they get their return on their investment.&#8221;<\/p>\n<p>READ MORE FROM FOX BUSINESS<\/p>\n<p>#Tom #Brady #GLP1 #drugs #kick #start #shortcut<\/p>\n","protected":false},"excerpt":{"rendered":"<p>eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss GLP-1 market growth&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[5621,758,5622,4892,5623,191,5620],"_links":{"self":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/2401"}],"collection":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2401"}],"version-history":[{"count":0,"href":"https:\/\/stock999.top\/index.php?rest_route=\/wp\/v2\/posts\/2401\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock999.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}